{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:31:09Z","timestamp":1780104669117,"version":"3.54.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pregnancy in women with mechanical heart valves (MHVs) poses significant challenges in balancing maternal thromboprophylaxis and fetal safety. Anticoagulation strategies must simultaneously prevent life-threatening valve thrombosis and minimize fetal risks, yet optimal management remains controversial. While warfarin offers effective thromboprophylaxis, its embryotoxicity at higher doses (&amp;gt;5\u2005mg\/day) contrasts with low molecular weight heparin (LMWH), which lacks consensus on thrombotic efficacy despite fetal safety advantages.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We report a case of a 30-year-old woman with mechanical mitral and tricuspid valves. She was maintained on low-dose warfarin (target INR 2.5\u20133.0) during early pregnancy. At 26\u201328 weeks of gestation, she developed exertional dyspnea; initial imaging showed stable valve function. At 33\u2009+\u20092 weeks, worsening symptoms and echocardiographic evidence of tricuspid valve dysfunction prompted anticoagulation transition from warfarin to LMWH combined with vitamin K. After achieving an INR &amp;lt;1.4, cesarean delivery was performed at 33\u2009+\u20093 weeks under general anesthesia, resulting in a live male infant without cardiac anomalies. Three days postpartum, mechanical tricuspid valve thrombosis with severe regurgitation was confirmed, necessitating bioprosthetic valve replacement on postoperative day 4. Maternal and neonatal outcomes were favorable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This case highlights the importance of individualized anticoagulation management, multidisciplinary coordination, and vigilant monitoring in optimizing outcomes for pregnant patients with MHVs. Tailored pharmacologic strategies represent key modifiable prenatal factors influencing both maternal safety and child health.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1596199","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:52:33Z","timestamp":1751435553000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanical tricuspid valve thrombosis in pregnancy: a case report and literature review on anticoagulation challenges and fetal protection strategies"],"prefix":"10.3389","volume":"13","author":[{"given":"San","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jacc.2018.10.075","article-title":"Use of medication for cardiovascular disease during pregnancy: JACC state-of-the-art review","volume":"73","author":"Halpern","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"102109","DOI":"10.1016\/j.jaccas.2023.102109","article-title":"Mechanical aortic valve thromboembolism during pregnancy on low molecular weight heparin","volume":"27","author":"Philpott","year":"2023","journal-title":"JACC: Case Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.15585\/mmwr.mm6818e1","article-title":"Vital signs: pregnancy-related deaths, United States, 2011\u20132015, and strategies for prevention, 13 states, 2013\u20132017","volume":"68","author":"Petersen","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1097\/AOG.0000000000003243","article-title":"ACOG practice bulletin no. 212: pregnancy and heart disease","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/nrcardio.2015.172","article-title":"Use of medication for cardiovascular disease during pregnancy","volume":"12","author":"Pieper","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/S0140-6736(16)31139-4","article-title":"Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials","volume":"388","author":"Rodger","year":"2016","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/01.NAJ.0000921828.47893.d9","article-title":"Low-dose low-molecular-weight heparin for thromboprophylaxis during pregnancy","volume":"123","author":"Rosenberg","year":"2023","journal-title":"AJN Am J Nurs"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.cjca.2024.09.011","article-title":"Meta-analysis of risk factors for congenital heart disease: part 2, maternal medication, reproductive technologies, and familial and fetal factors","volume":"40","author":"Lemieux","year":"2024","journal-title":"Can J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"01127-X","DOI":"10.1016\/j.ajog.2024.10.055","article-title":"Treatment of early-onset fetal growth restriction with low molecular weight heparin does not prolong gestation: a randomized clinical trial","author":"Gonz\u00e1lez","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ogc.2018.01.011","article-title":"Maternal congenital heart disease in pregnancy","volume":"45","author":"Foeller","year":"2018","journal-title":"Obstet Gynecol Clin North Am"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1093\/eurheartj\/ehv288","article-title":"Pregnancy in women with congenital heart disease","volume":"36","author":"Greutmann","year":"2015","journal-title":"Eur Heart J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e000712","DOI":"10.1161\/JAHA.113.000712","article-title":"Pregnancy complicated by valvular heart disease: an update","volume":"3","author":"Nanna","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehs270","article-title":"Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European society of cardiology","volume":"34","author":"Roos-Hesselink","year":"2013","journal-title":"Eur Heart J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.acvd.2011.04.001","article-title":"Pregnancy in women with heart disease in sub-Saharan Africa","volume":"104","author":"Diao","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e576S","DOI":"10.1378\/chest.11-2305","article-title":"Antithrombotic and thrombolytic therapy for valvular disease","volume":"141","author":"Whitlock","year":"2012","journal-title":"Chest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jcmg.2012.10.016","article-title":"Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis","volume":"6","author":"\u00d6zkan","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"B28","DOI":"10.1016\/j.ajog.2022.03.036","article-title":"Society for maternal-fetal medicine consult series #61: anticoagulation in pregnant patients with cardiac disease","volume":"227","author":"Pacheco","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1161\/CIRCULATIONAHA.113.001145","article-title":"Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator","volume":"128","author":"\u00d6zkan","year":"2013","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"36","DOI":"10.17659\/01.2016.0010","article-title":"Antenatally diagnosed binder syndrome in newborn following maternal warfarin intake in first trimester","volume":"6","author":"Malik","year":"2016","journal-title":"J Case Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23880\/whsj-16000224","article-title":"Pre-conception counseling","volume":"8","author":"Haider","year":"2024","journal-title":"Women's Health Sci J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1093\/eurheartj\/ehy340","article-title":"2018 ESC guidelines for the management of cardiovascular diseases during pregnancy","volume":"39","author":"Regitz-Zagrosek","year":"2018","journal-title":"Eur Heart J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3000605231192773","DOI":"10.1177\/03000605231192773","article-title":"Treasure to the mother and threat to the fetus: case report of warfarin-associated fetal intracranial hemorrhage and review of literature","volume":"51","author":"Shan","year":"2023","journal-title":"J Int Med Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000531310","article-title":"Warfarin-associated fetal subdural hematoma causing severe neurodevelopmental delay: a case report","volume":"8","author":"Safra","year":"2023","journal-title":"Biomed Hub"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/eurheartj\/ehx032","article-title":"Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis","volume":"38","author":"D\u2019Souza","year":"2017","journal-title":"Eur Heart J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/CIRCULATIONAHA.108.190377","article-title":"ACC\/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis","volume":"118","author":"Nishimura","year":"2008","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European society of cardiology (ESC)","volume":"32","author":"Regitz-Zagrosek","year":"2011","journal-title":"Eur Heart J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ccl.2020.09.010","article-title":"Valvular heart disease in pregnancy","volume":"39","author":"Lewey","year":"2021","journal-title":"Cardiol Clin"},{"key":"B28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.xjon.2023.05.001","article-title":"Pregnancy outcomes in women with a mitral valve prosthesis: a systematic review and meta-analysis","volume":"14","author":"Grashuis","year":"2023","journal-title":"JTCVS Open"},{"key":"B29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/heartjnl-2015-308476","article-title":"Cardiac output and related haemodynamics during pregnancy: a series of meta-analyses","volume":"102","author":"Meah","year":"2016","journal-title":"Heart"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2400179","DOI":"10.1183\/13993003.00179-2024","article-title":"Right heart function during and after pregnancy in women with pulmonary arterial hypertension","volume":"64","author":"Olsson","year":"2024","journal-title":"Eur Respir J"},{"key":"B31","first-page":"3686","article-title":"Application of Doppler ultrasound in detecting uterine artery and umbilical artery blood flow in pregnant women with hypertensive disorders during pregnancy","volume":"32","author":"Li","year":"2017","journal-title":"Chin Matern Child Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"200330","DOI":"10.1183\/16000617.0330-2020","article-title":"Sex and gender in pulmonary arterial hypertension","volume":"30","author":"Cheron","year":"2021","journal-title":"Eur Respir Rev"},{"key":"B33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1042\/cs0950115","article-title":"In utero programming of chronic disease","volume":"95","author":"Barker","year":"1998","journal-title":"Clin Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/GRF.0b013e31829cb9ca","article-title":"The obstetric origins of health for a lifetime","volume":"56","author":"Barker","year":"2013","journal-title":"Clin Obstet Gynecol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/AOG.0000000000001110","article-title":"Disseminated intravascular coagulation syndromes in obstetrics","volume":"126","author":"Cunningham","year":"2015","journal-title":"Obstet Gynecol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3949\/ccjm.75a.072272","article-title":"Anticoagulants and pregnancy: when are they safe?","volume":"76","author":"Gibson","year":"2009","journal-title":"Cleve Clin J Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1596199\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:52:33Z","timestamp":1751435553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1596199\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":36,"alternative-id":["10.3389\/fped.2025.1596199"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1596199","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"article-number":"1596199"}}